The percentage of Tetherin expressed intracellularly was calculated by multiplying 1 minus the ratio of surface versus total Tetherin expression by 100. Data were based on triplicate measurements, error bars correspond to standard deviations and differences between means were calculated using a 2-tailed Student's t test.
Supporting Figure 4. Blocking B6 Tetherin endocytosis with Dynasore.
(A) Representative histograms demonstrating that treatment of B6 Tetherin transfected 293T cells with the endocytosis inhibitor Dynasore resulted in increased MFI levels. (B) At 5 µM Dynasore dose, there was no significant difference in Tetherin MFI levels between treated B6 Tetherin and untreated NZW Tetherin. Data were based on triplicate measurements, error bars correspond to standard deviations and differences between means were calculated using a 2-tailed Student's t test.
Supporting Figure 5. Blocking B6 Tetherin endocytosis with a dominant-negative dynamin mutant.
293T cells were co-transfected with untagged Tetherin (250 ng) and either wild-type or K44A Dynamin-eGFP (1 µg) constructs. After 2 days, the cells were subjected to flow cytometry. (A) Gating strategy and Tetherin cell surface expression analysis. Tetherin expression levels were analyzed from gated eGFP+ cells. Right panels correspond to representative histograms, showing increased B6 Tetherin surface levels following co-expression with the dominantnegative K44A dynamin mutant. (B) Increased B6 Tetherin MFI following blockade of endocytosis using a dominant-negative dynamin mutant. (C) Increased percentage of B6 Tetherin expression following blockade of endocytosis using a dominant-negative dynamin mutant. For panels B and C, data were based on triplicate measurements, error bars correspond to standard deviations and differences between means were calculated using a 2-tailed Student's t test.
Supporting Figure 6. B6 Tetherin cell surface expression is dominant over NZW Tetherin in vitro.
Tetherin MFI levels in 293T cells following equimolar co-transfection of B6 and NZW Tetherin (250 ng each) were compared to 500 ng individual transfections with B6 or NZW Tetherin. (A) Distinct histogram profiles were observed between B6 and NZW Tetherin (left), but not when B6 and NZW Tetherin were co-transfected at equimolar levels (right). (B) Equimolar B6:NZW cotransfection resulted in decreased Tetherin MFI levels, consistent with the formation of a heterodimer that is endocytosed as efficiently as B6 Tetherin. Data were based on triplicate measurements, error bars correspond to standard deviations and differences between means were calculated using a 2-tailed Student's t test.
Supporting Figure 7. Baseline information on B6, NZW and F 1 hybrid mice.
Spleens from uninfected B6, NZW and F 1 hybrid mice were harvested. Tetherin MFI levels in (A) B cells and (B) erythroblasts. Each dot corresponds to a one mouse analyzed. (C) Baseline spleen mass for these three strains were equivalent. Differences between means were calculated using a 2-tailed Student's t test.
